Overview

Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria

Status:
Completed
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
This is an observational safety and efficacy study on dihydroartemisinin-piperaquine in Timika, Indonesia with a 42 day follow up period.
Details
Lead Sponsor:
Menzies School of Health Research
Collaborators:
Eijkman Institute for Molecular Biology
Eijkman Institute for Molecular Biology, Jakarta, Indonesia
World Health Organization
Treatments:
Artemisinins
Artenimol
Dihydroartemisinin
Piperaquine